Abstract
Aspergillosis may develop as a granulomatous, necrotizing, and cavitary disease that frequently affects the lungs (1),but may also disseminate to other organs (2) The causative agents of the disease are fungi belonging to the genus Aspergillus. Several Aspergillus spp. have been implicated as human pathogens, namely, A. fumigatus, A. niger, A. flavus, A. terreus, A. nidulans, and A. clavatus. Recently, A. ustus has also emerged as an opportunistic pathogen in immunocompromised patients (3).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tomee, J. F. and van der Werf, T. S. Pulmonary aspergillosis. Neth. J. Med., 59, 244–258, 2001.
Emmons, C. W., Binford, C. H., and Utz, J. P. Medical Mycology, 2nd ed. Leaand Febiger, Philadelphia, 256, 1970.
Gene, J., Azon-Masoliver, A., Guarro, J., et al. Cutaneous infection caused by Aspergillus ustus, an emerging opportunistic fungus in immunosuppressed patients. J. Clin. Microbiol., 39, 1134–1136, 2001.
Sugimura, S., Yoshida, K., Oba, H., et al. Two cases of invasive pulmonary aspergillosis in non-immunocompromised hosts. Nippon Kyobu Shikkan Gakkai Zasshi, 32, 1032, 1994.
Muller, M., Fallen, H., and Zoller, L. Pulmonary aspergillosis in an immunocompetent female patient. Dtsch. Med. Wochenschr.,119, 760, 1994 [see also: Dtsch. Med. Wochenschr.,119, 1716and 1717, 1994].
Valluri, S., Moorthy, R. S., Liggett, P. E., and Rao, N. A. Endogeneous Aspergillus endophthalmitis in an immunocompetent individual. Int. Ophthalmol., 17, 131, 1993.
Ko, J. P., Kim, D. H., and Shepard, J. A. Pulmonary aspergillosis in an immunocompetent patient. J. Thorac. Imaging, 17, 70–73, 2002.
Jeanrot, C., Guigui, P., Groussard, O., and Deburge, A. Spinal epidural aspergillosis due to a lung aspergilloma despite long-term itraconazole treatment. Rev. Chir. Orthop. Repatrice Appar. Mot., 87, 596–600, 2001.
Elgamal, E. A. and Murshid, W. R. Intracavitary administration of amphotericin B in the treatment of cerebral aspergillosis in a non-immunocompromised patient: case report and review of the literature. Br. J. Neurosurg., 14, 137–141, 2000.
Murthy, J. M., Sundaram, C., Prasad, V. S., Purohit, A. K., Rammurti, S., and Laxmi, V. Aspergillosis of central nervous system: a study of 21 patients seen in a university hospital in South India. J. Assos. Physicians India, 48, 677681, 2000.
Wise, G. J. Genitourinary fungal infections: a therapeutic conundrum. Expert Opin. Pharmacother., 2, 121–126, 2001.
Nenoff, P., Kliem, C., Mittag, M., Horn, L. C., Niederwieser, D., and Haustein, U. F. Secondary cutaneous aspergillosis due to Aspergillus flavus in an acute myeloid leukaemia patient following stem cell transplantation. Eur. J. Dermatol., 12, 93–98, 2002.
Ozsahin, H., Wacker, P., Brundler, M. A., et al. Fatal myocardial aspergillosis in an immunosuppressed child. J. Pediatr. Hematol. Oncol., 23, 456–459, 2001.
Nosari, A., Oreste, P., Cairoli, R., et al. Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion. Am. J. Hematol., 68, 231–236, 2001.
Buchheidt, D., Spiess, B., and Hehlmann, R. Systemic infections with Aspergillus species in patients with hematological malignancies: current serological and molecular diagnostic approaches. Onkologie, 24, 531–536, 2001.
Karthaus, M. and Bohme, A. Therapy of invasive organ mycoses in patients with systemic hematologic disease. Wien Med. Wochenschr., 151, 80–88, 2001.
Takagi, K., Yoshida, A., Yamauchi, T., et al. Successful treatment of Aspergillus spondylodiscitis with high-dose itraconazole in a patient with acute myelogenous leukemia. Leukemia, 15, 1670–1671, 2001.
Park, K. U., Lee, H. S., Kim, C. J., and Kim, E. C. Fungal discitis due to Aspergillus terreus in a patient with acute lymphoblastic leukemia. J. Korean Med. Sci., 15, 704–707, 2000.
Grandiere-Perez, L., Asfar, P., Foussard, C., Chennebault, J. M., Penn, P., and Degasne, I. Spondylodiscitis due to Aspergillus terreus during an efficient treatment against invasive pulmonary aspergillosis. Intensive Care Med., 26, 1010–1011, 2000.
Ng, A., Gadong, N., Kelsey, A., Denning, D. W., Leggate, J., and Eden, O. B. Successful treatment of Aspergillus brain abscess in a child with acute lymphoblastic leukemia. Pediatr. Hematol. Oncol., 17, 497–504, 2000.
Nucci, M., Pulcheri, W., Bacha, P. C., et al. Amphotericin B followed by itraconazole in the treatment of disseminated fungal infections in neutropenic patients. Mycoses, 37, 433, 1994.
Caillot, D., Mannone, L., Cuisenier, B., and Couaillier, J. F. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients. Clin. Microbiol. Infect., 7 (Suppl. 2), 54–61, 2001.
Goldberg, S. L., Geha, D. J., Marshall, W. F., Inwards, D. J., and Hoagland, H. C. Successful treatment of simulataneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole. Clin. Infect. Dis., 16, 803, 1993.
Hadley, S. and Karchmer, A. W. Fungal infections in solid organ transplant recipients. Infect. Dis. Clin. North Am., 9, 1045, 1995.
Marks, W. H., Florence, L., Lieberman, J., et al. Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation, 61, 1771, 1996.
Bowden, R. A., Cays, M., Gooley, T., Mamelok, R. D., and van Burik, J. A. Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant. J. Infect. Dis., 173, 1208, 1996.
Warnock, D. W. Fungal complications of transplantation: diagnosis, treatment and prevention. J. Antimicrob. Chemother., 36 (Suppl. B), 73, 1995.
Kruger, W., Stockschläder, M., Rüssmann, B., et al. Experience with liposomal amphotericin B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation. Br. J. Haematol., 91, 684, 1995.
Choi, S. S., Milmoe, G. J., Dinndorf, P. A., and Quinones, R. R. Invasive Aspergillus sinusitis in pediatric bone marrow transplant patient: evaluation and management. Arch. Otolaryngol. Head Neck Surg., 121, 1188, 1995.
Cassuto-Viguier, E., Mondain, J. R., Van Elslande, L., et al. Fatal outcome of Aspergillus fumigatus arthritis in a renal transplant recipient. Transplant. Proc., 27, 2461, 1995.
Franco, M., Van Elslande, L., Robino, C., et al. Aspergillus arthritis of the shoulder in a renal transplant recipient: failure of itraconazole therapy. Rev. Rhum. Engl. Ed., 62, 215, 1995.
Hagensee, M. E., Bauwens, J. E., Kjos, B., and Bowden, R. A. Brain abscess following marrow transplantation: experince at the Fred Hutchinson Cancer Research Center, 1984–1992. Clin. Infect. Dis., 19, 402, 1994.
Collins, L. A., Samore, M. H., Roberts, M. S., et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J. Infect. Dis., 170, 644, 1994.
Wang, S. S., Chu, S. H., Lee, Y. C., Chang, S. C., and Yang, P. C. Successful treatment of invasive pulmonary aspergillosis. Transplant. Proc., 26, 2329, 1994.
Saah, D., Drakos, P. E., Elidan, J., Braverman, I., Or, R., and Nagler, A. Rhinocerebral aspergillosis in patients undergoing bone marrow transplantation. Ann. Otol. Rhinol. Laryngol., 103, 306, 1994.
O’Donnell, M. R., Schmidt, G. M., Tegmeier, B. R., et al. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J. Clin. Oncol., 12, 827, 1994.
McWhinney, P. H., Kibbler, C. C., Hamon, M. D., et al. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years’ experience. Clin. Infect. Dis., 17, 397, 1993.
Holt, R. I., Kwan, J. T., Sefton, A. M., and Cunningham, J. Successful treatment of concomitant pulmonary nocardiosis and aspergillosis in an immunocompromised renal patient. Eur. J. Clin. Microbiol. Infect. Dis., 12, 110, 1993.
Paya, C. V. Fungal infections in solid-organ transplantations. Clin. Infect. Dis., 16, 677, 1993.
Monteforte, J. S. and Wood, C. A. Pneumonia caused by Nocardia nova and Aspergillus fumigatus after cardiac transplantation. Eur. J. Clin. Microbiol. Infect. Dis., 12, 112, 1993.
Grow, W. B., Moreb, J. S., Roque, D., et al. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital. Bone Marrow Transplant., 29, 15–19, 2002.
Watanabe, C., Yajima, S., Taguchi, T., et al. Successful unrelated bone marrow transplantation for a patient with chronic granulomatous disease and associated resistant pneumonitis and Aspergillus osteomyelitis. Bone Marrow Transplant., 28, 83–87, 2001.
Kim, S. W., Nah, M. Y., Yeum, C. H., et al. Pelvic aspergillosis with tubo-ovarien abscess in a renal transplant recipient. J. Infect., 42, 215–217, 2001.
Barnes, C., Berkovitz, R., Curtis, N., and Waters, K. Aspergillus laryngotracheobronchial infection in a 6-year-old girl following bone marrow transplantation. Int. J. Pediatr. Otorhinolaryngol., 59, 59–62, 2001.
Kontoyiannis, D. P., Andersson, B. S., Lewis, R. E., and Raad, I. I. Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B. Clin. Infect. Dis., 32, E94 — E96, 2001.
Jantunen, E., Ruutu, P., Piilonen, A., Volin, L., Parkkali, T., and Ruutu, T. Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant., 26, 759–762, 2000.
Jantinen, E., Piilonen, A., Volin, L., et al. Diagnostic aspects of invasive Aspergillus infections in allogenic BMT recipients. Bone Marrow Transplant., 25, 867–871, 2000.
Ho, P. L. and Yuen, K. Y. Aspergillosis in bone marrow transplant recipients. Crit. Rev. Oncol. Hematol., 34, 5569, 2000.
Yeldandi, V., Laghi, F., McCabe, M. A., et al. Aspergillus and lung transplantation. J. Heart Lung Transplant., 14, 883, 1995.
Tomee, J. F., Mannes, G. P., van der Bij, W., et al. Serodiagnosis and monitoring of Aspergillus infections after lung transplantation. Ann. Intern. Med., 125, 197, 1996.
Heurlin, N., Bergstrom, S. E., Winiarski, J., et al. Fungal pneumonia: the predominant lung infection causing death in children undergoing bone marrow transplantation. Acta Paediatr., 85, 168, 1996.
Mannes, G. P., van der Bij, W., and de Boer, W. J. Liposomal amphotericin B in three lung transplant recipients. J. Heart Lung Transplant., 14, 781, 1995.
Flume, P. A., Egan, T. M., Paradowski, L. J., Detterbeck, F. C., Thompson, J. T., and Yankaskas, J. R. Infectious complications of lung transplantation: impact of cystic fibrosis. Am. J. Respir. Crit. Care Med., 149, 1601, 1994.
Mehrad, B., Paciocco, G., Martinez, F. J., Ojo, T. C., Iannettoni, M. D., and Lynch, J. P. 3rd. Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest, 119, 169–175, 2001.
Gilbey, J. G., Chalermskulrat, W., and Aris, R. M. Aspergillus endocarditis in a lung transplant recipient. A case report and review of the transplant literature. Ann. Transplant., 5, 48–53, 2000.
Collazos, J., Mayo, J., Martinez, E., and Ibarra, S. Prosthetic vascular graft infection due to Aspergillus species: case report and literature review. Eur. J. Clin. Microbiol. Infect. Dis., 20, 414–417, 2001.
Beckers, E. A. and Strack van Schijndel, R. J. Aspergillus spondylodiskitis in a patient with chronic obstructive pulmonary disease. Eur. J. Intern. Med., 13, 139–142, 2002.
Nenoff, P., Kellermann, S., Horn, L. C., et al. Case report. Mycotic arteritis due to Aspergillus fumigatus in a diabetic with retrobulbar aspergillosis and mycotic meningitis. Mycoses, 44, 407–414, 2001.
Berner, R., Sauter, S., Michalski, Y., and Niemeyer, C. M., Central venous catheter infection by Aspergillus fumigatus in a patient with B-type non-Hodgkin lymphoma, Med. Pediatr. Oncol., 27, 202, 1996.
Meyohas, M. C., Roux, P., Poirot, J. L., Meynard, J. L., and Frottier, J. Aspergillosis in acquired immunodeficiency syndrome. Pathol. Biol. (Paris), 42, 647, 1994.
Keating, J. J., Rogers, T., Petrou, M., et al. Management of pulmonary aspergillosis in AIDS: an emerging clinical problem. J. Clin. Pathol., 47, 805, 1994.
Libanore, M., Pastore, A., Frasconi, P. C., et al. Invasive multiple sinusitis by Aspergillus fumigatus in a patient with AIDS. Int. J. STD AIDS, 5, 293, 1994.
Tumbarello, M., Ventura, G., Caldarola, G., Morace, G., Cauda, R., and Ortona, L. An emerging opportunistic infection in HIV patients: a retrospective analysis of 11 cases of pulmonary aspergillosis. Eur. J. Epidemiol., 9, 638, 1993.
Lortholary, O., Meyohas, M. C., Dupont, B., et al. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. Am. J. Med., 95, 177, 1993.
Blanco Espinosa, A., Moreno Izarra, J., Regueiro Lopez, J. C., Anglada Curado, F. J., and Requena Tapia, M. J. Renal abscess in patients with HIV infection in the era of highly active antiretroviral therapy. Actas Urol. Esp., 25, 396–399, 2001.
Keller, M. J. and Sax, P. E. Aspergillus sinusitis in two HIV-infected men. AIDS Clin. Care, 9, 94, 100, 1997.
Stanford, D., Boyle, M., and Gillespie, R. Human immunodeficiency virus-related primary cutaneous aspergillosis. Australas. J. Dermatol., 41, 112–116, 2000.
Le Conte, P., Blanloeil, Y., Germaud, P., Morin, O., and Moreau, P. Invasive aspergillosis in intensive care. Ann. Fr. Anesth. Reanim., 14, 198, 1995 [see also: Ann. Fr. Anesth. Reanim., 14, 454, 1995 ].
Blanloeil, Y., Francois, T., Germaud, P., et al. Invasive aspergillosis in surgical intensive care patients. Ann. Fr. Anesth. Reanim., 12, 379, 1993.
Pegues, D. A., Lasker, B. A., McNeil, M. M., Hamm, P. M., Lundal, J. L., and Kubak, B. M. Cluster of cases of invasive aspergillus in a transplant intensive care unit: evidence of person-to-person airborne transmission. Clin. Infect. Dis., 34, 412–416, 2002.
Pouchelon, E., Murris-Espin, M., Didier, A., et al. Invasive pulmonary aspergillosis in 4 patients with acute decompensation of chronic respiratory insufficiency. Rev. Mal. Respir, 10, 325, 1993.
Bodey, G. P. and Vartivarian, S. Aspergillosis. Eur. J. Clin. Microbiol. Infect., 8, 413, 1989.
Pittet, D., Huguenin, T., Dharan, S., et al. Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 154, 541, 1996.
Logan, P. M. and Muller, N. L. High-resolution computed tomography and pathologic findings in pulmonary aspergillosis: a pictorial essay. Can. Assoc. Radiol. J., 47, 444, 1996.
Denning, D. W. Chronic forms of pulmonary aspergillosis. Clin. Microbiol. Infect., 7 (Suppl. 2), 25–31, 2001.
Ikeue, T., Nishiyama, H., Yokomise, H., et al. A case of non-invasive pulmonary aspergillosis that rapidly deteriorated. Nihon Kokyuki Gakkai Zasshi, 39, 582–586, 2001.
Kwon-Chung, K. J. and Bennett, J. E. Medical Mycology. Leaand Febiger, Philadelphia, 217, 1992.
de Aquino, M. Z., Brasciner, A., Cristofani, L. M., et al. Aspergillosis in immunocompromised children with acute myeloid leukemia and bone marrow aplasia: report of two cases. Rev. Inst. Med. Trop. Sao Paolo, 36, 465, 1994.
Young, R. C., Bennett, J. E., Vogel, C. L., Carbone, P. P., and DeVita, V. T. Aspergillus - the spectrum of the disease in 98 patients. Medicine (Baltimore), 49, 107, 1970.
Nong, H., Li, J., and Huang, G. Aspergillosis of the larynx. Chung Hua Erh Pi Yen Hou Ko Tsa Chih, 30, 111, 1995.
Viale, P., Di Matteo, A., Sisti, M., Voltolini, F., Paties, C., and Alberici, F. Isolated kidney localization of invasive aspergillosis in a patient with AIDS. Scand. J. Infect. Dis., 26, 767, 1994.
Hovi, L., Saarinen, U. M., Donner, U., and Lindqvist, C. Opportunistic osteomyelitis in the jaws of children on immunosuppressive chemotherapy. J. Pediatr. Hematol. Oncol., 18, 90, 1996.
Liu, Z., Hou, T., Shen, Q., Liao, W., and Xu, H. Osteomyelitis of sacral spine caused by Aspergillus versicolor with neurologic defects. Chin. Med. J., 108, 472, 1995.
D’Hoore, K. and Hoogmartens, M. Vertebral aspergillosis: a case report and review of the literature. Acta Orthop. Belg., 59, 306, 1993.
Baumann, P. A., Cunningham, B., Patel, N. S., and Finn, H. A. Aspergillus fumigatus infection in a mega prosthetic total knee arthroplasty: salvage by staged reimplantation with 5-year follow-up. J. Arthroplasty, 16, 498–503, 2001.
Ansari, M. S. Nabi, G., Singh, I., Hemal, A. K., and Bhan, A. Mycotic abdominal aortic aneurysm: a fatal sequel to concomitant prostatic and renal aspergillosis. Case report and review of the literature. Urol. Int., 66, 36–37, 2001.
Kato, T., Usami, I., Morita, H., et al. Chronic necrotizing pulmonary aspergillosis in pneumoconiosis: clinical and radiologie findings in 10 patients. Chest, 121, 118–127, 2002.
Routsi, C., Platsouka, E., Prekates, A., Rontogianni, D., Paniara, O., and Roussos, C. Aspergillus bronchitis causing atelectasis and acute respiratory failure in an immunocompromised patient. Infection, 29, 243–244, 2001.
Ko, S. C., Chen, K. Y., Hsueh, P. R., Luh, K. T., and Yang, P. C. Fungal empyema thoracis: an emerging clinical entity. Chest, 117, 1672–1678, 2000.
Mazzoni, A., Ferrarese, M., Manfredi, R., Facchini, A., Sturani, C., and Nanetti, A. Primary lymph node invasive aspergillosis. Infection, 24, 37, 1996.
Gonzalez-Crespo, M. R. and Gomez-Reino, J. J. Invasive aspergillosis in systemic lupus erythematosus. Semin. Arthritis Rheum., 24, 304, 1995.
Nenoff, P., Horn, L.-C., Mierzwa, M., et al. Peracute disseminated fatal Aspergillus fumigatus sepsis as a complication of corticoid-treated systemic lupus erythematosus. Mycoses, 38, 467, 1995.
Collazos, J., Martinez, E., Flores, M., and Mayo, J. Aspergillus pneumonia successfully treated with itraconazole in a patient with systemic lupus erythematosus. Clin. Invest., 72, 920, 1994.
Tanis, B. C., Verburgh, C. A., van’t Wout, J. W., and van der Pijl, J. W. Aspergillus peritonitis in peritoneal dialysis: case report and a review of the literature. Nephrol. Dial. Transplant., 10, 1240, 1995 [see also: Nephrol. Dial. Transplant., 10, 1124, 1995 ].
Miles, A. M. and Barth, R. H. Aspergillus peritonitis: therapy, survival, and return to peritoneal dialysis. Am. J. Kidney Dis., 26, 80, 1995.
Nguyen, M. H. and Muder, R. R. Aspergillus peritonitis in a continuous ambulatory peritoneal dialysis patient: case report and review of the literature. Diagn. Microbiol. Infect. Dis., 20, 99, 1994.
Girmenia, C., Gastaldi, R., and Martino, P. Catheter-related cutaneous aspergillosis complicated by fungemia and fatal pulmonary infection in an HIV-positive patient with acute lymphocytic leukemia. Eur. J. Clin. Microbiol. Infect. Dis., 14, 524, 1995.
Baker, R. D. Pulmonary mucormycosis. Am. J. Pathol., 32, 287, 1956
Jurgens Mestre, A., Martinez Vecina, V., Peiro Cabrera, G., et al. Mucormycosis of paranasal sinuses: benign type. Report of one case. Acta Otorrinolaringol. Esp., 45, 117–120, 1994.
Libshitz, H. I. and Pagani, J. J. Aspergillosis and mucormycosis: two types of opportunistic fungal pneumonia. Radiology, 140, 301, 1981.
Borges, V. Neto, Medeiros, S., Ziomkowski, S., and Machado, A. Successful treatment of mucormycosis and Aspergillus sp. rhinosinusitis in an immunocompromised patient. Braz. J. Infect. Dis., 2, 209–211, 1998.
British Thoracic and Tuberculosis Association. Aspergilloma and residual cavities: the result of a resurvey. Tubercle, 51, 227, 1970.
Kueh, Y. K., Chionh, S. B., Ti, T. Y., Tan, W. C., and Lee, Y. S. Tuberculosis and invasive pulmonary aspergillosis in a young woman with a myelodysplastic syndrome. Singapore Med. J., 36, 107, 1995.
Freundlich, I. M., Libshitz, H. I., Glassman, L. M., and Israel, H. L. Sarcoidosis: typical and atypical thoracic manifestations and complications. Clin. Radiol., 21, 376, 1970.
Israel, H. L. and Ostrow, A. Sarcoidosis and aspergillosis. Am. J. Med., 47, 243, 1969.
Mariotta, S., Giuffreda, E., Tramontano, F., Treggiari, S., Ricci, A., and Schmid, G. Therapeutic approach in pulmonary mycetoma. Analysis of 27 patients. Panminerva Med., 43, 161–165, 2001.
Israel, H. L., Lenchner, G. S., and Atkinson, G. W. Sarcoidosis and aspergilloma: the role of surgery. Chest, 82, 430, 1982.
Potter, M. European experience with oral solution and intravenous itraconazole. Oncology (Huntingt.), 15 (11 Suppl. 9), 27–32, 2001.
Bagnoud, M., Baglivo, E., Hengstler, J., Safran, A. B., Poumaras, C. J., and Leuenberger, P. Endogenous fungal endophthalmitis: results of antifungal treatment with and without vitrectomy. Klin. Monatsbl. Augenheilkd., 218, 398400, 2001.
Kueter, J. C., MacDiarmid, S. A., and Redman, J. F. Anuria due to bilateral ureteral obstuction by Aspergillus flavus in an adult male. Urology, 59, 601, 2002.
Perez-Arellano, J. L., Angel-Moreno, A., Belon, E., Frances, A., Santana, O. E., and Martin-Sanchez, A. M. Isolated renouretic aspergilloma due to Aspergillus flavus: case report and review of the literature. J. Infect., 42, 163–165, 2001.
Gokahmetoglu, S., Koc, A. N., and Patiroglu, T. Case report. Fatal Aspergillus flavus pericarditis in a patient with acute myeloblastic leukaemia. Mycoses, 43, 65–66, 2000.
Demaria, R. G., Durrleman, N., Rispail, P., et al. Aspergillus flavus mitral valve endocarditis after lung abscess. J. Heart Valve Dis., 9, 786–790, 2000.
Rao, K. and Saha, V. Medical management of Aspergillus flavus endocarditis. Pediatr. Hematol. Oncol., 17, 425427, 2000.
Morelli, S., Sgreccia, A., Bernardo, M. L., Della Rocca, C., Gallo, A., and Valesini, G. Primary aspergillosis of the larynx in a patient with Felty’s disease. Clin. Exp. Rheumatol., 18, 523–524, 2000.
Sridhar, M. S., Garg, P., Bansal, A. K., and Gopinathan, U. Aspergillus flavus keratitis after laser in situ keratomileusis. Am. J. Ophthalmol., 129, 802–804, 2000.
Marroni, M., Cao, P., Repetto, A., Prattichizzo, L., Parlani, G., and Fiorio, M. Aspergillus flavus infection of an aortic bypass. Eur. J. Clin. Microbiol. Infect. Dis., 20, 439–441, 2001.
Trachana, M., Roilides, E., Gompakis, N., Kanellopoulou, K., Mpantouraki, M., and Kanakoudi-Tsakalidou, F. Case report. Hepatic abscesses due to Aspergillus terreus in an immunodeficient mice. Mycoses, 44, 415–418, 2001.
Silva, M. E., Malogolowkin, M. H., Hall, T. R., Sadeghi, A. M., and Krogstad, P. Mycotic aneurysm of the thoracic aorta due to Aspergillus terreus: case report and review. Clin. Infect. Dis., 31, 1144–1148, 2000.
Lass-Florl, C., Rath, P., Niederwieser, D., et al. Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-house plants. J. Hosp. Infect., 46, 31–35, 2000.
Glimp, R. A. and Bayer, A. S. Pulmonary aspergilloma: diagnostic and therapeutic consideration. Arch. Intern. Med., 143, 303, 1983.
Flye, M. W. and Sealy, W. C. Pulmonary aspergilloma: a report of its occurrence in two patients with cyanotic heart disease. Ann. Thorac. Surg., 20, 196, 1975.
Longbottom, J. L., Pepys, J., and Clive, F. T. Diagnostic precipitin test in Aspergillus pulmonary mycetoma. Lancet, 1, 588, 1964.
Wong, J., McCracken, G., Ronan, S., and Aronson, I. Coexistent cutaneous Aspergillus and cytomegalovirus infection in a liver transplant recipient. J. Am. Acad. Dermatol., 44 (2 Suppl.), 370–372, 2001.
Cortet, B., Richard, R., Deprez, X., et al. Aspergillus spondylodiscitis: successful conservative treatment in 9 cases. J. Rheumatol., 21, 1287, 1994.
Peters-Christodoulou, M. N., de Beer, F. C., Bots, G. T., Ottenhoff, T. M., Thomson, J., and van’t Hout, J. W. Treatment of postoperative Aspergillus fumigatus spondylodiscitis with itraconazole. Scand. J. Infect. Dis., 23, 373, 1991.
Richard, R., Lucet, L., Mejjad, O., et al. Aspergillus spondylodiscitis: apropos of 3 cases. Rev. Rhum. Ed. Fr., 60, 45, 1993.
Cortet, B., Deprez, X., Triki, R., et al. Aspergillus spondylodiscitis: apropos of 5 cases. Rev. Rhum. Ed. Fr., 60, 37, 1993.
Roilides, E., Dimitriadou, A., Kadiltsoglou, I., et al. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Immunol., 158, 322, 1997.
Walsh, T. J. Invasive aspergillosis in patients with neoplastic diseases. Semin. Respir. Infect., 5, 111, 1990.
Cohen, M. S., Isturiz, R. E., Malech, H. L., et al. Fungal infection in chronic granulomatous disease: the importance of the phagocyte in defense against fungi. Am. J. Med., 71, 59, 1981.
Denning, D. W., Follansbee, S. E., Scolaro, M., Norris, S., Edelstein, H., and Stevens, D. A. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N. Engl. J. Med., 324, 654, 1991.
Rowen, J. L., Correa, A. G., Sokol, D. M., Hawkins, H. K., Levy, M. L., and Edwards, M. S. Invasive aspergillosis in neonates: report of five cases and literature review. Pediatr. Infect. Dis. J., 11, 576, 1992.
Weinberger, M., Elattar, I., Marshall, D., et al. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore), 71, 24, 1992.
Brooks, R. G., Hofflin, J. M., Jamieson, S. W., Stinson, E. B., and Remington, J. S. Infectious complications in heart-lung transplant recipients. Am. J. Med., 79, 412, 1985.
Morrison, V. A., Haake, R. J., and Weisdorf, D. J. The spectrum of non-Candida fungal infections following bone marrow transplantation. Medicine (Baltimore), 72, 78, 1993.
Waldorf, A. R. and Diamond, R. D. Aspergillosis and mucormycosis, in Immunology of the Fungal Disease, Cox, R. A. Ed. CRC Press, Boca Raton, 29, 1989.
Schaffner, A., Douglas, H., and Braude, A. Selective protection against conidia by mononuclear and mycelia by polymononuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J. Clin. Invest., 69, 617, 1982.
Waldorf, A. R., Levitz, S., and Diamond, R. D. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J. Infect. Dis., 150, 752, 1984.
Levitz, S., Selsted, M. E., Ganz, T., Lehrer, R. I., and Diamond, R. D. In vitro killing of spores and hyphae of Aspergillus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J. Infect. Dis., 154, 483, 1986.
Diamond, R. D., Krzesicki, R., Epstein, B., and Jao, W. Damage to hyphal forms of fungi by human leukocytes in vitro: a possible host defense mechanism in aspergillosis and mucormycosis. Am. J. Pathol., 91, 313, 1978.
Polak-Wyss, A. Protective effect of human granulocyte colony-stimulating factor on Cryptococcus and Aspergillus infections in normal and immunosuppressed mice. Mycoses,34, 205, 1991
Rex, J. H., Bennett, J. E., Gallin, J. I., Malech, H. L., Decarlo, E. S., and Melnick, D. A. In vivo interferon-y therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. J. Infect. Dis., 163, 849, 1991.
Roilides, E., Holmes, A., Blake, C., Venzon, D., Pizzo, P. A., and Walsh, T. J. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-y. J. Infect. Dis., 170, 894, 1994.
Roilides, E., Sein, T., Holmes, A., Blake, C., Pizzo, P. A., and Walsh, T. J. Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Infect. Dis., 172, 1028, 1995.
Roilides, E., Uhlig, K., Venzon, D., Pizzo, P. A., and Walsh, T. J. Granulocyte colony-stimulating factor and interferon-y enhance the oxidative responses and the damage caused by human neutrophils to Aspergillus fumigatus hyphae in vitro. Infect. Immun., 61, 1185, 1993.
Walsh, T., Gonzalez, C., Lyman, C., et al. Human recombinant macrophage colony-stimulating factor augments pulmonary host defense against Aspergillus fumigatus. Proc. Annu. Mtg. Am. Soc. Microbiol., American Society for Microbiology, Washington, D.C., abstract # F-27 (p. 593 ), 1994.
Mehrad, B. Moore, T. A., and Standiford, T. J. Macrophage inflammatory protein-1 alpha is a critical mediator of host defense against invasive pulmonary aspergillosis in neutropenic hosts. J. Immunol.,165, 962–968, 2000.
Patterson, T. F., Kirkpatrick, W. R., White, M., et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore), 79, 250–260, 2000 [see also: Medicine (Baltimore), 79, 281–282, 2000 ].
Stevens, D. A., Kan, V. L., Judson, M. A., et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin. Infect. Dis., 30, 696–709, 2000 [see also: Clin. Infect. Dis., 32, 321, 2001 ].
Gerstl, B., Weidmen, W. H., and Newmann, A. V. Pulmonary aspergillosis: report of two cases. Ann. Intern. Med., 28, 662, 1948.
Klossek, J. M., Peloquin, L., Fourcroy, P. J., Ferne, J. C., and Fontanel, J. P. Aspergillomas of the sphenoid sinus: a series of 10 cases treated by endoscopic sinus surgery. Rhinology, 34, 179, 1996.
Klossek, J. M., Serrano, E., Peloquin, L., Percodani, J., Fontanel, J.-P., and Pessey, J.-J. Functional endoscopic sinus surgery and 109 mycetomas of paranasal sinuses. Laryngoscope, 107, 112, 1997.
Klinjongol, C., Chanyasawath, S., Pakdirat, B., and Pakdirat, P. One-stage surgical treatment of pulmonary aspergilloma with cavernostomy and muscle transposition flap: a case report. J. Med. Assoc. Thai., 78, 692, 1995.
Robinson, L. A., Reed, B.C., Galbraith, T. A., Alonso, A., Moulton, A. L., and Fleming, W. H. Pulmonary resection for invasive Aspergillus infections in immunocompromised patients. J. Thorac. Cardiovasc. Surg., 109, 1182, 1196, 1995.
Pidhorecky, I. Urschel, J., and Anderson, T. Resection of invasive pulmonary aspergillosis in immunocompromised patients. Ann. Surg. Oncol.,7, 312–217, 2000.
Georgiev, V. St. Opportunistic/nosocomial infections: treatment and developmental therapeutics. I. Aspergillosis. Respiration, 59, 291, 1992.
Georgiev, V. St. Opportunistic/nosocomial infections: treatment and developmental therapeutics. II. Azoles and other antifungal drugs. Respiration, 59, 303, 1992.
Karci, B., Burhanoglu, D., Erdem, T., Hilmioglu, S., Inci, R., and Veral, A. Fungal infections of the paranasal sinuses. Rev. Laryngol. Otol. Rhinol. (Bord.), 122, 31–35, 2001.
Rizk, S. S., Kraus, D. H., Gerresheim, G., and Mudan, S. Aggressive combination treatment for invasive fungal sinusitis in immunocompromised patients. Ear Nose Throat J., 79, 278–280, 2000.
Min, Y. G., Kim, H. S., Kang, M. K., and Han, M. H. Aspergillus sinusitis: clinical aspects and treatment outcomes. Otolaryngol. Head Neck Surg., 115, 49, 1996.
Parker, K. M., Nicholson, J. K., Cezayirli, R. C., and Biggs, P. J. Aspergillosis of the sphenoid sinus: presentation as a pituitary mass and postoperative gallium-67 imaging. Surg. Neurol., 45, 354, 1996.
Teh, W., Matti, B. S., Marisiddaiah, H., and Minamoto, G. Y. Aspergillus sinusitis in patients with AIDS: report of three cases and review. Clin. Infect. Dis., 21, 529, 1995.
Marple, B. F. Allergic fungal rhinosinusitis: current theories and management strategies. Laryngoscope, 111, 1006 1119, 2001.
Jaing, T. H., Yang, C. P., Hung, I. J., Chiu, C. H., and Hsueh, C. Successful treatment of invasive Aspergillus rhinosinusitis in a child with acute myeloid leukemia. J. Otolaryngol., 29, 257–259, 2000.
Bodey, G. P. Fungal infections in cancer patients. Ann. NYAcad. Sci., 544, 431, 1988.
Moosa, M. Y., Alangaden, G. J., Manavathu, E., and Chandrasekar, P. H. Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis. J. Antimicrob. Chemother., 49, 209–213, 2002.
Maksymiuk, A. W., Thongprasert, S., Hopfer, R., Luna, M., Fainstein, V., and Bodey, G. P. Systemic candidiasis in cancer patients. Am. J. Med., 77 (4D), 20, 1984.
Aisner, J., Schimpff, S. C., and Wiernik, P. H. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann. Intern. Med., 86, 539, 1977.
Pennington, J. E. Successful treatment of Aspergillus pneumonia in hematologic neoplasia. N. Engl. J. Med., 295, 426, 1976.
Pizzo, P. A. Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patient. J. Pediatr., 98, 341, 1981.
Pizzo, P. A. Infectious complications in the child with cancer. II. Management of specific infectious organisms. J. Pediatr., 98, 513, 1981.
Denning, D. W. and Stevens, D. A. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev. Infect. Dis., 12, 1147, 1990.
Jewkes, J., Kay, P. H., Paneth, M., and Citron, K. M. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax, 38, 572, 1983.
Pagano, L., Ricci, P., Nosari, A., et al. Fatal haemoptysis in pulmonary filamentous mycosis: an underdevaluated cause of death in patients with acute leukaemia in haematological complete remission: a retrospective study and review of the literature. Br. J. Haematol., 89, 500, 1995.
Shapiro, M. J., Albelda, S. M., Mayock, R. L., and McLean, G. K. Severe hemoptysis associated with pulmonary aspergilloma: percutaneous intracavitary treatment. Chest, 94, 1255, 1988.
Cochrane, L. J., Morano, J. U., Norman, J. R., and Mansel, J. K. Use of intracavitary amphotericin B in a patient with aspergilloma and recurrent hemoptysis. Am. J. Med., 90, 654, 1991.
Bennett, M. R., Weinbaum, D. L., and Fiehler, P. C. Chronic necrotizing pulmonary aspergillosis treated by endobronchial amphotericin B. South. Med. J., 83, 829, 1990.
Rodriguez, V., Bardwil, J. M., and Bodey, G. P. Primary aspergilloma cured with amphotericin B. South. Med. J., 64, 396, 1971.
Fisher, B. D., Armstrong, D., Yu, B., and Gold, J. W. M. Invasive aspergillosis: progress in early diagnosis and treatment. Am. J. Med., 71, 571, 1981.
Weber, R. S. and Lopez-Berestein, G. Treatment of invasive aspergillosis sinusitis with liposomal-amphotericin B. Laryngoscope, 97, 937, 1987.
Bahadur, S., Kacker, S. K., D’Souza, B., and Chopra, P. Paranasal sinus aspergillosis. J. Laryngol. Otol., 97, 836, 1983.
Schwartz, R. S., Macintosh, F. R., Schrier, S. L., and Greenberg, P. L. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer, 53, 411, 1984.
Lashley, P. M., Callender, D. P., Graham, A. C., Gopwani, H., and Garrigues, S. Aspergillosis in a patient with acute lymphoblastic leukaemia. West Indian Med. J., 40, 37, 1991.
Kusumoto, S., Matsuda, A., Fukuda, M., et al. Aspergillosis of the maxillary sinus in a patient with Phl positive acute lymphoblastic leukemia: a case report. Rinsho Ketsueki, 31, 1512, 1990.
Ho, P. C., Tolentino, F. I., and Baker, A. S. Successful treatment of exogenous aspergillus endophthalmitis: a case report. Br. J. Ophthalmol., 68, 412, 1984.
Harrell, E. R., Wolter, J. R., and Gutow, R. F. Localized aspergilloma of the eyelid: treatment with local amphotericin B. Arch. Ophthalmol., 76, 322, 1966.
Harris, G. L. and Mill, B. R. Orbital aspergillosis: conservative debridement and local amphotericin irrigation. Ophthal. Plast. Reconstr. Surg., 5, 207, 1989.
Matsuo, T., Nakagawa, H., and Matsuo, N. Endogenous Aspergillus endophthalmitis associated with periodontitis. Ophthalmologica, 209, 109, 1995.
Goodman, M. L. and Coffey, R. J. Stereotactic drainage of Aspergillus brain abscess with long-term survival: case report and review. Neurosurgery, 24, 96, 1989.
Shuper, A., Levitsky, H. I., and Cornblath, D. R. Early invasive CNS aspergillosis: an easily missed diagnosis. Neuroradiology, 33, 183, 1991.
Kravitz, S. P. and Berry, P. L. Successful treatment of Aspergillus peritonitis in a child undergoing continuous cycling peritoneal dialysis. Arch. Intern. Med., 146, 2061, 1986.
Kerr, C., Perfect, J., Craven, P., et al. Fungal peritonitis in patients of continuous ambulatory peritoneal dialysis. Ann. Intern. Med., 99, 334, 1983.
Skorodin, M. S., Gergans, G. A., Zvetina, J. R., and Siever, J. R. Xenon-133 evidence of bronchopleural fistula healing during treatment of mixed aspergillosis and tuberculosis empyema. J. Nucl. Med., 23, 688, 1982.
Conneally, E., Cafferkey, M. T., Daly, P. A., Keana, C. T., and McCann, S. R. Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. Bone Marrow Transplant., 5, 403, 1990.
Kuo, P. H., Lee, L. N., Yang, P. C., Chen, Y. C., and Luh, K. T. Aspergillus laryngotracheobronchitis presenting as stridor in a patient with peripheral T cell lymphoma. Thorax, 51, 869, 1996.
Hay, R. J. Use of ambisome, liposomal amphotericin B, in systemic fungal infections: preliminary findings of a European multicenter study, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takahashi, H., Eds. Marcel Dekker, New York, 323, 1992.
Lequaglie, C. Liposomal amphotericin B (AmBisome): efficacy and safety of low-dose therapy in pulmonary fungal infections. J. Antimicrob. Chemother., 49 (Suppl. A), 49–50, 2002.
Chopra, R. AmBisome in the treatment of fungal infections: the UK experience. J. Antimicrob. Chemother., 49 (Suppl. A), 43–47, 2002.
Ringdèn, O. and Tollemar, J. Liposomal amphotericin B (AmBisome) treatment of invasive fungal infections in immunocompromised children. Mycoses, 36, 187, 1993.
Walsh, T. J., Goodman, J. L., Pappas, P., et al. Safety, tolerance, and pharmacokinetics of high-dose liposomal ampho-tericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob. Agents Chemother.,45, 3487–3496, 2001.
Mehta, R., Lopez-Berestein, G., Hopfer, R., Mills, K., and Juliano, R. L. Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochem. Biophys. Acta, 770, 230, 1984.
Dornbusch, H. J., Urban, C. E., Pinter, H., et al. Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (AmBisome), granulocyte colony-stimulating factor, and surgery: report of five cases. Pediatr. Hematol. Oncol., 12, 577, 1995.
Khan, Z. U., Gopalakrishnan, G., al-Awadi, K., et al. Renal aspergilloma due to Aspergillus flavus. Clin. Infect. Dis., 21, 210, 1995.
Purcell, I. F. and Corris, P. A. Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema. Thorax, 50, 1321, 1995.
Hospenthal, D. R., Byrd, J. C., and Weiss, R. B. Successful treatment of invasive aspergillosis complicating prolonged treatment-related neutropenia in acute myelogenous leukemia with amphotericin B lipid complex. Med. Pediatr. Oncol., 25, 119, 1995.
Mendicute, J., Ondarra, A., Eder, F., et al., The use of collagen shields impregnated with amphotericin B to treat Aspergillosis keratomycosis. CLAO J., 21, 252, 1995.
Xie, L., Dong, X., and Shi, W. Treatment of fungal keratitis by penetrating keratoplasty. Br. J. Ophthalmol., 85, 1070 1074, 2001.
Ellis, M., Watson, R., McNabb, A., Lukic, M. L., and Nork, M. Massive intracerebral aspergillosis responding to combination high dose liposomal amphotericin B and cytokine therapy without surgery. J. Med. Microbiol., 51, 70–75, 2002.
Hammerman, K. J., Sarosi, G. A., and Tosh, F. E. Amphotericin B in the treatment of saprophytic forms of pulmonary aspergillosis. Am. Rev. Respir. Dis., 109, 57, 1974.
Kilman, J. W., Ahn, C., Andrews, N. C., and Klassen, K. Surgery for pulmonary aspergillosis. J. Thorac. Cardiovasc. Surg., 57, 642, 1969.
Reddy, P. A., Christianson, C. S., Brasher, C. A., Larsh, H., and Sutaria, M. Comparison of treated and untreated pulmonary aspergilloma: an analysis of 16 cases. Am. Rev. Respir. Dis., 101, 928, 1970.
Peer, E. T. Case of aspergillosis treated with amphotericin B. Dis. Chest, 38, 222, 1960.
Tabeta, H. and Moriya, T. A case of chronic necrotizing pulmonary aspergillosis in which intravenous infusion of amphotericin B was effective. Nippon Kyobu Shikkan Gakkai Zasshi, 33, 342, 1995.
Krakowka, P., Traczyk, K., Walczak, J., Halweg, H., Elsner, Z., and Pawlicka, L. Local treatment of aspergilloma of the lung with a paste containing nystatin and amphotericin B. Tubercle, 51, 184, 1970.
Hargis, J. L., Bone, R. C., Stewart, J., Rector, N., and Hiller, F. C. Intracavitary amphotericin B in the treatment of symptomatic pulmonary aspergillosis. Am. J. Med., 68, 389, 1980.
Henderson, A. H. and Pearson, J. E. G. Treatment of bronchopulmonary aspergillosis with observation on the use of natamycin. Thorax, 23, 519, 1968.
Ramirez, R. J. Pulmonary aspergillosis. N. Engl. J. Med., 271, 1281, 1964.
Giron, J., Poey, C., Fajadet, P., et al., Palliative percutaneous treatment under x-ray computed tomographic control of inoperable pulmonary aspergilloma: apropos of 30 cases. Rev. Mal. Respir., 12, 593, 1995.
Shirai, T., Taniguchi, M., Imokawa, S., Sugiura, W., Sato, A., and Genma, H. Usefulness of percutaneous instillation of antifungal agents for pulmonary aspergilloma. Kekkaku, 70, 9, 1995.
Furuse, F., Nakanishi, Y., Kotoh, H., et al., Percutaneous intracavitary treatment of pulmonary aspergilloma - clinical efficacy and prognosis. Nippon Kyobu Shikkan Gakkai Zasshi, 32, 538, 1994.
Schmitt, H. J., Bernard, E. M., Haeuser, M., and Armstrong, D. Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis. Antimicrob. Agents Chemother., 32, 1676, 1988.
Beyer, J., Schwartz, S., Barzen, G., et al. Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis. Infection, 22, 143, 1994.
Cahill, K. V., Hogan, C. D., Koletar, S. L., and Gersman, M. Intraorbital injection of amphotericin B for palliative treatment of Aspergillus orbital abscess. Ophthal. Plast. Reconstr. Surg., 10, 276, 1994.
Inai, K., Ueda, T., Kagawa, D., Iwasaki, H., and Nakamura, T. A case of erythroleukemia associated with lung aspergilloma successfully treated with continuous drip infusion of amphotericin B. Kansenshogaku Zasshi, 69, 602, 1995.
Maesaki, S., Kawamura, S., Miyazaki, Y., Tomono, K., Tashiro, T., and Kohno, S. Effect of sequential combination of amphotericin B and azole antifungal agents against Aspergillus fumigatus. J. Infect. Chemother., 5, 125–129, 1999.
Gevender, S., Rajoo, R., Goga, I. E., and Charles, R. W. Aspergillus osteomyelitis of the spine. Spine, 16, 746, 1991.
Yokoyama, S., Taniguchi, H., Kondo, Y., Matsumoto, K., and Okada, A A case of bronchopulmonary aspergillosis recurring in a residual tuberculosis cavity. Kekkaku, 64, 579, 1989.
Saral, R. Candida and Aspergillus infections in immunocompromised patients: an overview. Rev. Infect. Dis., 13, 487, 1991.
Bogner, J. R., Luftl, S., Middeke, M., and Spengel, F. Successful drug therapy in Aspergillus endocarditis. Dtsch. Med. Wochenschr., 115, 1833, 1990.
Talbot, G. H., Huang, A., and Provencher, M. Invasive aspergillus rhinosinusitis in patients with acute leukemia. Rev. Infect. Dis., 13, 219, 1991.
Rodenhuis, S., Beaumont, F., Kauffman, H. F., and Sluiter, H. J. Invasive pulmonary aspergillosis in a nonimmunosuppressed patient: successful management with systemic amphotericin and flucytosine and inhaled amphotericin. Thorax, 39, 78, 1984.
Shadomy, S., Wagner, G., Espinel-Ingroff, A., and Davis, B. A. In vitro studies with combinations of 5-fluorocytosine and amphotericin B. Antimicrob. Agents Chemother., 8, 117, 1975.
Spiteri, M. A., McCall, J., and Clarke, S. W. Successful management of primary invasive pulmonary aspergillosis. Br. J. Dis. Chest, 80, 297, 1986.
Henze, G., Aldenhoff, P., Stephani, U., Grosse, G., Kazner, E., and Staib, F. Successful treatment of pulmonary and cerebral aspergillosis in an immunosuppressed child. Eur. J. Pediatr., 138, 263, 1982.
Codish, S. D., Tobias, J. S., and Hannigan, M. Combined amphotericin B-flucytosine therapy in Aspergillus pneumonia. J. Am. Med. Assoc., 241, 2418, 1979.
Donahue, R. E., Johnson, M. M., Zon, L. I., Clark, S. C., and Groopman, J. E. Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature, 326, 200, 1987.
Kotler, D. P., Gaetz, H. P., Lange, M., Klein, E. B., and Holt, P. R. Enteropathy associated with acquired immunodeficiency syndrome. Ann. Intern. Med., 101, 421, 1984.
Lazzarin, A. and Capsoni, F. Disseminated aspergillosis. Am. J. Dis. Child., 136, 136, 1982.
Raubitschek, A. A., Levin, A. S., Stites, D. P., Phillips, J. C., and Ahonkhai, V. I. Normal granulocyte infusion therapy for aspergillosis in chronic granulomatous disease. Pediatrics, 51, 230, 1973.
Elgefors, B., Haugstvedt, S., Brorsson, J. E., and Esbjomer, E. Disseminated aspergillosis treated with amphotericin B and surgery in a boy with chronic granulomatous disease. Infection, 8, 174, 1980.
Corrado, M. L., Cleri, D., Fikrig, S. M., Shaw, E. B., and Fudenberg, H.H. Aspergillosis in chronic granulomatous disease: therapeutic consideration. Am. J. Dis. Child., 134, 1092, 1980.
Beyt, B. E. Jr., Cannon III, R. O., and Tuteur, P. G. Successful treatment of invasive pulmonary aspergillosis in the immunocompromised host. South. Med. J., 71, 1164, 1978.
Ribner, B., Keusch, G. T., Hanna, B. A., and Perloff, M. Combination amphotericin B- rifampin therapy for pulmonary aspergillosis in a leukemic patient. Chest, 70, 681, 1976.
Colp, C. R. and Cook, W. A. Successful treatment of pleural aspergillosis and bronchopleural fistula. Chest, 68, 96, 1975.
Sato, A., Nakatani, K., Matsushita, Y., et al., Chronic necrotizing pulmonary aspergillosis treated with itraconazole and inhaled amphotericin B. Nippon Kyobu Shikkan Gakkai Zasshi, 33, 1141, 1995.
Coleman, J. M., Hogg, G. G., Rosenfeld, J. V., and Waters, K. D. Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery - case report and review of the literature. Neurosurgery, 36, 858, 1995.
Maesaki, S., Kohno, S., Tanaka, K., et al. A case of pulmonary aspergilloma successfully treated with combination therapy of intracavitary injection of amphotericin B and intravenous administration of urinastatin. Nippon Kyobu Shikkan Gakkai Zasshi, 31, 1327, 1993.
Milne, L. J. R. Mycological studies in the use of clotrimazole in bronchopulmonary aspergillosis and neonatal and vaginal candidiasis. Postgrad. Med. J., 50 (Suppl. 1), 20, 1974.
Evans, E. G. V., Watson, D. A., and Mattews, N. R. Pulmonary aspergilloma in a child treated with clotrimazole. Br. Med. J., 4, 599, 1971.
Mahgoub, E. S. Laboratory and clinical experience with clotrimazole (BAY b 5097). Sabouraudia, 10, 212, 1972.
Tettenborn, D. Akute toxizitat and lokale vertraglichkeit von clotrimazole. Arzneimit.-Forsch., 22, 1272, 1972.
Dixon, D., Wagner, G. E., Shadomy, S., and Shadomy, H. J. In vitro comparison of the antifungal activities of R 34,000, miconazole and amphotericin B. Chemotherapy, 24, 364, 1978.
Hamamoto, T., Watanabe, K., and Ikemoto, H. Endobronchial miconazole for pulmonary aspergilloma. Ann. Intern. Med., 98, 1030, 1983.
Heel, R. C., Brogden, R. N., Pakes, G. E., Speight, T. M., and Avery, G. S. Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections. Drugs, 19, 7, 1980.
Hay, R. J. Historical perspectives and projected needs for systemic azole antifungals, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takahashi, H., Eds. Marcel Dekker, New York, 173, 1992.
Maryniak, D. M., Mullen, G. B., Allen, S. D., Mitchell, J. T. Kinsolving, C. R., and Georgiev, V. St., Studies on antifungal agents, In vitro activity of novel cis-5-alkoxy (or acyloxy)alkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2methylisoxazolidine derivatives. Arzneimit.-Forsch., 40, 95, 1990.
Farquhar, D. L., Munro, J. F., Milne, J. R., and Piris, J. Ketoconazole and fungal sinusitis. Scott. Med. J., 29, 192, 1984.
Heel, R.C., Brogden, R. N., Carmine, A., Morley, P. A., Speight, T. M., and Avery, G. S. Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs, 23, 1, 1982.
Sonino, N. The use of ketoconazole as an inhibitor of steroid production. N. Engl. J. Med., 317, 812, 1987.
Van Cutsem, J., Van Gerven, F., Van de Ven, M. A., Borgers, M., and Janssen, P. A. J. Itraconazole, a new triazole that is orally active against aspergillosis. Antimicrob. Agents Chemother., 26, 527, 1984.
Viviani, M. A., Tortorano, A. M., Langer, M., et al. Experience with itraconazole in cryptococcosis and aspergillosis. J. Infect., 18, 151, 1989.
Tricot, G., Joosten, E., Boogaerts, M. A., Vande Pitte, J., and Cauwenbergh, G. Ketoconazole versus itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Rev. Infect. Dis., 9 (Suppl. 1), S94, 1987.
Dupont, B. and Drouhet, E. Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results. Rev. Infect. Dis., 9 (Suppl. 1), S71, 1987.
Denning, D. W., Tucker, R. M., Hanson, L. H., and Stevens, D. A. Treatment of invasive aspergillosis with itraconazole. Am. J. Med., 86, 791, 1989.
Utili, R., Zampino, R., De Vivo, F., et al. Improved outcome of pulmonary aspergillosis in heart transplant recipients with early diagnosis and itraconazole treatment. Clin. Transplant., 14 (4 Part 1), 282–286, 2000.
Lebeau, B., Pelloux, H., Pinel, C., Michallet, M., Gout, J. P., Pison, C., Delormas, P., Bru, J., P., Brion, J. P., Ambroise-Thomas, P., and Grillo, R. Itraconazole in the treatment of aspergillosis: a study of 16 cases. Mycoses, 37, 171, 1994.
Cauwenbergh, G., De Doncker, P., Stoops, K., De Dier, A. M., Goyvaaerts, H., and Schuermans, V. Itraconazole in the treatment of human mycoses: review of three years of clinical experience. Rev. Infect. Dis., 9 (Suppl. 1), S146, 1987.
Graybill, J. R., Kaster, S. R., and Drutz, D. J. Treatment of experimental murine aspergillosis with BAY n 7133. J. Infect. Dis., 148, 898, 1983.
Thienpont, D., Van Cutsem, J., Van Cauteren, H., and Marsboom, R. The biological and toxicological properties of imazalil. Arzneimit.-Forsch., 31, 309, 1981
Molina Utrilla, R., Lao Luque, J., Perello Scherdel, E., Companyo Hermo, C., and Casamitjana Claramunt, F. Otomycosis: case reports of 18 months in the General University Hospital of the Valle de Hebron in Barcelona. An. Otorrinolaringol. Ibero Am., 21, 255, 1994.
Ulbricht, H. and Worz, K. Therapy with ciclopirox lacquer of onychomycoses caused by molds. Mycoses, 37 (Suppl. 1), 97, 1994.
Van Cutsem, J., Van Gerven, F., and Janssen, P. A. Oral and parenteral therapy with saperconazole (R 66905) of invasive aspergillosis in normal and immunocompromised animals. Antimicrob. Agents Chemother., 33, 2063, 1989.
Tanio, T., Ohashi, N., Saji, I., and Fukusawa, M. SM-9164, an active enantiomer of SM- 8668 (SCH 39304): oral and parenteral activity in systemic fungal infection models, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takahashi, H., Eds. Marcel Dekker, New York, 473, 1992.
Hector, R. F. and Yee, E. Evaluation of BAY R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis. Antimicrob. Agents Chemother., 34, 448, 1990.
Holt, R. J. and Newman, R. L. Mycological studies in the use of clotrimazole in bronchopulmonary aspergillosis and neonatal and vaginal candidiasis. Postgrad. Med. J., 50 (Suppl. 1), 20, 1974.
Crompton, G. K. and Milne, L. J. Treatment of bronchopulmonary aspergillosis with clotromazole. Br. J. Dis. Chest, 67, 301, 1973.
Jones, B. R., Richards, A. B., and Clayton, Y. M. Clotrimazole in the treatment of ocular infection by Aspergillus fumigatus. Postgrad. Med. J., 50 (Suppl. 1), 39, 1974.
Bolaert, J., Daneels, R., Van Landuyt, H., and Symoens, J. Miconazole plasma levels in healthy subjects and in patients with impaired renal function. Chemotherapy, 6, 165, 1976.
Ito, A. Therapeutic results with miconazole in Japan, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takahashi, H., Eds. Marcel Dekker, New York, 183, 1992.
Uchida, K. and Yamaguchi, H. Bioassay for miconazole and its levels in human body fluids. Chemotherapy, 32, 541, 1984.
Mukae, H., Iwamoto, M., Tagawa, H., et al. A case of Aspergillus empyema with bronchopleural fistula. Nippon Kyobu Shikkan Gakkai Zasshi, 28, 1482, 1990.
Watanabe, A., Ohizumi, K., Motomiya, M., et al., Therapeutic efficacy of miconazole on deep-seated fungal infections in the respiratory tract system. Jpn. J. Antibiot., 43, 1392, 1990.
Maeda, T. A case of chronic necrotizing pulmonary aspergillosis effectively treated with miconazole inhalation. Nippon Kyobu Shikkan Gakkai Zasshi, 32, 168, 1994.
Huang, Y. C., Colaizzi, J. L., Bierman, R. H., Woestenborghs, R., and Heykants, J. Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers. Antimicrob. Agents Chemother., 30, 206, 1986.
Tones, M. A., Mohamed, J., Cavazos-Adame, H., and Martinez, L. A. Topical ketoconazole for fungal keratitis. Am. J. Ophthalmol., 100, 293, 1985.
Singh, S. M., Khan, R., Sharma, S., and Chatterjee, P. K. Clinical and experimental mycotic corneal ulcer caused by Aspergillus fumigatus and the effect of oral ketoconazole in the treatment. Mycopathologia, 106, 133, 1989.
O’Day, D. M., Moore, T. E. Jr., and Aronson, S. B. Deep fungal corneal abscess: combined corticosteroid therapy. Arch. Ophthalomol., 86, 414, 1971.
Coriglione, G., Stella, G., Gafa, L., et al. Neosartorya fischeri var. fischeri (Wehmer) Malloch and Cain 1972 (anamorph: Aspergillus fischerianus Samson and Gams 1985) as a cause of mycotic keratitis. Eur. J. Epidemiol., 6, 382, 1990.
Humphrey, M. J., Jevons, S., and Tarbit, M. H. Pharmacokinetic evaluation of UK 49,858, a metabolically stable triazole antifungal in animals and humans. Antimicrob. Agents Chemother., 28, 648, 1985.
Anaissie, E. J., Kontoyiannis, D. P., Hule, C., et al. Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections. J. Infect. Dis., 172, 599, 1995.
Onist, P. and Tauris, P. Short-term curative treatment of Aspergillus fumigatus pneumonia with fluconazole. Scand. J. Infect. Dis., 22, 749, 1990.
Yoneda, R. A clinical study of fluconazole in pulmonary aspergillosis. Jpn. J. Antibiot., 42, 40, 1989.
Takamoto, M., Ishibashi, T., Shinoda, A., et al., A clinical study on fluconazole against pulmonary mycosis associated with respiratory diseases. Jpn. J. Antibiot., 47, 1145, 1994 [correction in Jpn. J. Antibiot., 48, 162, 1995 ].
Nakashima, M. The clinical study of fluconazole against pulmonary mycosis: effects of fluconazole on pulmonary cryptococcosis and aspergillosis, and its pharmacokinetics in patients. Jpn. J. Antibiot., 42, 127, 1989.
Winston, D. J., Hathorn, J. W., Schuster, M. G., Schiller, G. J., and Territo, M. C. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer. Am. J. Med., 108, 282–289, 2000 [see also: Am. J. Med., 108, 343–345, 2000 ].
Heykants, J., Van Peer, A., Van de Velde, V., et al. The clinical pharmacokinetics of itraconazole: an overview. Mycoses, 32 (Suppl. 1), 67, 1989.
Niwa, H., Yamakawa, Y., Kondo, K., et al., A high concentration of itraconazole in an aspergilloma. Nippon Kyobu Shikkan Gakkai Zasshi, 34, 67, 1996.
Borgers, M. and Van de Ven, M. A. Degenerative changes in fungi after itraconazole treatment. Rev. Infect. Dis., 9 (Suppl. 1), S33, 1987.
Dannaoui, E., Borel, E., Monier, M. F., Piens, M. A., Picot, S., and Persat, F. Acquired itraconazole resistance in Aspergillus fumigatus. J. Antimicrob. Chemother., 47, 333–340, 2001.
Warnock, D. W. Itraconazole and fluconazole: new drugs for deep fungal infection. J. Antimicrob. Chemother., 24, 275, 1989.
Kreisel, W. Therapy of invasive aspergillosis with itraconazole: our own experiences and review of the literature. Mycoses, 37 (Suppl. 2), 42, 1994.
Denning, D. W., Van Wye, J. E., Lewiston, N. J., and Stevens, D. A. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest, 100, 813, 1991.
Niimi, T., Kajita, M., and Saito, H. Necrotizing bronchial aspergillosis in a patient receiving neoadjuvant chemotherapy for non-small cell lung carcinoma. Chest, 100, 277, 1991.
Kamei, K., Kohno, N., Tabeta, H., et al. The treatment of pulmonary aspergilloma with itraconazole. Kansenshogaku Zasshi, 65, 808, 1991.
Kramer, M. R., Denning, D. W., Marshall, S. E., et al. Ulcerative tracheobronchitis after lung transplantation: a new form of invasive aspergillosis. Am. Rev. Respir. Dis., 144, 552, 1991.
Milleron, B., Roger, V., Roux, P., et al. Semi-invasive aspergillosis with involvement of the thoracic wall cured by itraconazole. Rev. Pneumol. Clin., 46, 175, 1990.
Watanabe, T., Kuriyama, K., and Kamei, K. Case of pulmonary aspergillosis successfully treated with itraconazole. Jpn. J. Antibiot., 53, 103–106, 2000.
Dupont, B. Itraconazole therapy in aspergillosis: study in 49 patients. J. Am. Acad. Dermatol., 23, 607, 1990.
Yamamoto, T., Suzuki, K., Yamakoshi, M., Tamamoto, T., and Ariga, K. A case of itraconazole-induced hypokalemia with pulmonary aspergilloma. Kansenshogaku Zasshi, 69, 1413, 1995.
Noppen, M., Claes, I., Maillet, B., Meysman, M., Monsieur, I., and Vincken, W. Three cases of bronchial stump aspergillosis: unusual clinical presentations and beneficial effect of oral itraconazole. Eur. Respir. J., 8, 477, 1995.
Kloss, S., Schuster, A., Schroten, H., Lamprecht, J., and Wahn, V. Control of proven pulmonary and suspected CNS aspergillus infection with itraconazole in a patient with chronic granulomatous disease. Eur. J. Pediatr., 150, 483, 1991.
Neijens, H. J., Frenkel, J., de Muinck Keiser-Schrama, S. M., Dzoljic-Danilovic, G., Meradji, M., and van Dongen, J. J. Invasive Aspergillus infection in chronic granulomatous disease: treatment with itraconazole. J. Pediatr., 115, 1016, 1989.
van’t Wout, J. W., Raven, E. J., and van der Meer, J. M. Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease. J. Infect., 20, 147, 1990.
Lamprecht, J., Kuhn, A. G., and Sauer, S. Aspergillus mastoiditis in infected granulomatosis: a case report. Laryngorhinootologia, 69, 341, 1990.
Saulsbury, F. T. Successful treatment of Aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease. Clin. Infect. Dis., 32, E137 — E139, 2001.
Touza Rey, F., Martinez Vazquez, C., Alonso Alonso, J., Mendez Pineiro, M. J., Rubianes Gonzalez, M., and Crespo Casai, M. The clinical response to interferon-gamma in a patient with chronic granulomatous disease and brain abscesses due to Aspergillus fumigatus. An. Med. Interna, 17, 86–87, 2000.
Witzig, R. S., Greer, D. L., and Hyslop, N. E. Jr. Aspergillus flavus mycetoma and epidural abscess successfully treated with itraconazole. J. Med. Vet. Mycol., 34, 133, 1996.
Gresenguet, G., Belec, L., Testat, J., Lesbordes, J. L., Dupont, B., and Georges, A. J. Pseudotumoral naso-sinusal aspergillosis stabilized by itraconazole. Med. Trop. (Mars.), 49, 73, 1989.
Massry, G. G., Hornblass, A., and Harrison, W. Itraconazole in the treatment of orbital aspergillosis. Ophthalmology, 103, 1467, 1996.
Rowe-Jones, J. M. and Freedman, A. R. Adjuvant itraconazole in the treatment of destructive sphenoid aspergillosis. Rhinology, 32, 203, 1994.
Impens, N., De Greve, J., De Beule, K., Meysman, M., De Beuckelaere, S., and Schandevyi, W. Oral treatment with itraconazole of aspergilloma in cavitary lung cancer. Eur. Respir. Dis., 3, 837, 1990.
Mori, T., Ebe, T., Isonuma, H., et al. Aspergilloma: comparison of treatment methods and prognoses. J. Infect. Chemother., 6, 233–239, 2000.
De Laurenzi, A. Aspergillosis in a cardiac transplant patient successfully treated with itraconazole. Clin. Transpl., 321, 1989.
Villard, C., Lacroix, C., Rabot, M. H., Rovira, J. C., and Jacquemin, J. L. Severe Aspergillus keratomycosis treated with itraconazole per os. J. Fr. Ophthalmol., 12, 323, 1989.
Scher, R. K. and Barnett, J. M. Successful treatment of Aspergillus flavus onychomycosis with oral itraconazole. J. Am. Acad. Dermatol., 23, 749, 1990.
Sanchez, C., Mauri, E., Dalmau, D., Quintana, S., Aparicio, A., and Garau, J. Treatment of cerebral aspergillosis with itraconazole: do high doses improve the prognosis? Clin. Infect. Dis., 21, 1485, 1995.
Elliott, J. A., Milne, L. J., and Cumming, D. Chronic necrotizing pulmonary aspergillosis treated with itraconazole. Thorax, 44, 820, 1989.
Van Cutsem, J. and Cauwenbergh, G. Results of itraconazole treatment in systemic mycoses in animals and man, in Recent Progress in Antifungal Chemotherapy, Yamaguchi, H., Kobayashi, G. S., and Takahashi, H., Eds. Marcel Dekker, New York, 203, 1992.
Gupta, P. K., Mahapatra, A. K., Gaind, R., Bhandari, S., Musa, M. M., and Lad, S. D. Aspergillus spinal epidural abscess. Pediatr. Neurosurg., 35, 18–23, 2001.
Sachs, M. K., Blanchard, L. M., and Green, P. J. Interaction of itraconazole and digoxin. Clin. Infect. Dis., 16, 400, 1993 [see also: Clin. Infect. Dis., 18, 259, 1994 ].
Wimberley, S. L., Haug, M. T. 3rd, Shermock, K. M., et al Enhanced cyclosporine-itraconazole interaction with cola in lung transplant recipients. Clin. Transplant., 15, 116–122, 2001.
Schiraldi, G. F., Lo Cicero, S. L., Colombo, M. D., Rossato, D., Ferrarese, M., and Soresi, E. Refractory pulmonary aspergillosis: compassionate trial with terbinafine. Br. J. Dermatol., 134(Suppl. 46 ), 25, 39, 1996.
Schiraldi, G. F., Colombo, M. D., Harari, S., et al. Terbinafine in the treatment of non-immunocompromised compassionate cases of bronchopulmonary aspergillosis. Mycoses, 39, 5, 1996.
Gupta, A. K., Gregurek-Novak, T., Konnikov, N., Lynde, C. W., Hofstader, S., and Summerbell, R. C. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature. J. Cutan. Med. Surg., 5, 206–210, 2001.
Rotoli, M., Sascaro, G., and Cavalieri, S. Aspergillus versicolor infection of the external auditory canal successfully treated with terbinafine. Dermatology 202, 143, 2001
Hoang, A. Caspofungin acetate: an antifungal agent. Am. J. Health Syst. Pharm., 58, 1206–1217, 2001.
Keating, G. M. and Jarvis, B. Caspofungin. Drugs, 61, 1121–1131, 2001.
Utz, J. P., German, J. L., Louria, D. B., Emmons, C. W., and Banter, F. C. Pulmonary aspergillosis with cavitation: iodide therapy associated with unusual electrolyte imbalance. N. Engl. J. Med., 260, 264, 1959.
Ramirez, R. J. Pulmonary aspergilloma. N. Engl. J. Med., 271, 1281, 1964.
Adelson, H. T. and Malcolm, J. A. Endocavitary treatment of pulmonary mycetomas. Am. Rev. Respir. Dis., 98, 87, 1968.
O’Connor, T. M., O’Donnell, A., Hurley, M., and Bredin, C. P. Allergic bronchopulmonary aspergillosis: a rare cause of pleural effusion. Respirology, 6, 361–363, 2001.
Vlahakis, N. E. and Aksamit, T. R. Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin. Proc., 76, 930–938, 2001.
Wark, P. A. and Gibson, P. G. Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment. Respirology, 6, 1–7, 2001.
Elphick, H. and Southern, K. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database Syst. Rev., (4), CD002204, 2000.
Vilar, M. E., Najib, N. M., Chowdhry, I., et al. Allergic bronchopulmonary aspergillosis as presenting sign of cystic fibrosis in an elderly man. Ann. Allergy Asthma Immunol., 85, 70–73, 2000.
D’Urzo, A. D. and Mclvor, A. R. Case report: allergic bronchopulmonary aspergillosis in asthma. Can. Fam. Physician, 46, 882–884, 2000.
Judson, M. A. and Stevens, D. A. Current pharmacotherapy of allergic bronchopulmonary aspergillosis. Expert Opin. Pharmacother., 2, 1065–1071, 2001.
Greenberger, P. A. Diagnosis and management of allergic bronchopulmonary aspergillosis. Allergy Proc., 15, 335, 1994.
Shale, D. J., Faux, J. A., and Lane, D. J. Trial of ketoconazole in non-invasive pulmonary aspergillosis. Thorax, 42, 26, 1987.
Rosenberg, M., Patterson, R., and Mintzer, R. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann. Intern. Med., 86, 405, 1977.
McCarthy, D. S. and Pepys, J. Allergic bronchopulmonary aspergillosis: clinical immunology. 1. Clinical features. Clin. Allergy, 1, 261, 1971.
Safirstein, B. H., D’ Souza, M., Simon, G., Tai, E. H.-C., and Pepys, J. Five-year follow-up of allergic bronchopulmonary aspergillosis. Am. Rev. Respir. Dis., 108, 450, 1973.
Pingleton, W. W., Hiller, F. C., Bone, R. C., Kerby, G. R., and Ruth, W. E. Treatment of allergic aspergillosis with triamcinolone acetonide aerosol. Chest, 71, 782, 1977.
Glimp, R. A. and Bayer, A. S. Pulmonary aspergulloma: diagnosis and therapeutic consideration. Arch. Intern. Med., 143, 303, 1983.
Shah, A., Khan, Z. U., Chaturvedi, S., Ramchandran, S., Randhawa, H. S., and Jaggi, O. P. Allergic bronchopulmonary aspergillosis with coexistent aspergilloma: a long-term follow up. J. Asthma, 26, 109, 1989.
Davies, D. and Somner, A. R. Pulmonary aspergilloma treated with corticosteroids. Thorax, 27, 156, 1972.
Stevens, E. A. M., Hilvering, C., and Ortie, N. G. M. Inhalation experiments with extracts of Aspergillus fumigatus on patients with allergic aspergillosis and aspergilloma. Thorax, 25, 11, 1970.
Slavin, R. G., Million, L., and Cherry, J. Allergic bronchopulmonary aspergillosis: characterization of antibodies and results of treatment. J. Allergy, 46, 150, 1970.
Slavin, R. G., Stanczyk, D. J., Lonigro, A. J., and Broun, G. O. Allergic bronchopulmonary aspergillosis: a North American rarity. Am. J. Med., 47, 306, 1969.
Stark, J. E. Allergic pulmonary aspergillosis successfully treated with inhalation of nystatin. Dis. Chest, 51, 96, 1967.
Henderson, A. H. and Pearson, J. E. G. Treatment of bronchopulmonary aspergillosis with observation on the use of natamycin. Thorax, 23, 519, 1968.
Crompton, G. K. and Milne, L. J. R. Treatment of bronchopulmonary aspergillosis with clotrimazole. Br. J. Dis. Chest, 67, 301, 1973.
Patterson, T. F., Kirkpatrick, W. R., White, M., et al. Proc. 36th Inresci. Conf. Antimicrob. Agents Chemother., American Society for Microbiology, Washington, DC, abstract # LM38, 1996.
Radha, T. G. and Viswanathan, R. Allergic bronchopulmonary aspergillosis. Respiration, 36, 104, 1978.
Currie, D. C., Lueck, C., Milburn, H. J., et al. Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis. Thorax, 45, 447, 1990.
Shah, A., Panchal, N., and Agarwal, A. K. Concomitant allergic bronchopulmonary aspergillosis and allergic Aspergillus sinusitis: a review of an uncommon association*. Clin. Exp. Allergy, 31, 1896–1905, 2001.
Lopez, L. and Evans, R. P. Drug therapy of aspergillosis otitis externa. Otolaryngol. Head Neck Surg., 88, 649, 1980.
Lohoue Petmy, J., Bengono Toure, G., and Founda Onana, A. A study of otomycoses in Yaounde. Rev. Laryngol. Otol. Rhinol. (Bord.), 117, 119, 1996.
Bezjak, V. and Arya, O. P. Otomycosis due to Aspergillus niger. East. Afr. Med. J., 47, 247, 1970.
Gregson, A. E. W. and LeTouche, C. J. The significance of mytotic infection in the etiology of otitis externa. J. Laryngol. Otol., 75, 167, 1961.
Mc Gonigle, J. J. and Jillson, O. F. Otomycosis: an entity. Arch. Dermatol., 95, 45, 1967.
Bear, V. D. Otitis externa: immediate and long-term results with flumethasone pivalate/iodochlorhydroxyquine ear drugs. Med. J. Aust., 1, 273, 1969.
Than, K. M., Naing, K. S., and Min, M. Otomycosis in Burma, and its treatment. Am. J. Trop. Med. Hyg., 29, 620, 1980.
Schoneback, J. and Zakrisson, J. E. Topical 5-fluorocytosine therapy in otomycosis. J. Laryngol. Otol., 88, 227, 1974.
Youssef, Y. A. and Abdou, M. H. Studies on fungus infection of the external ear. II. On the chemotherapy of otomycosis. J. Laryngol. Otol., 81, 1005, 1967.
Pavlenko, S. A. Otomycosis in the Kuznetsk region and organization of medical services for this group of population. Vestn. Otorinolaringol., 70, 1990.
Gordon, G. and Giddings, N. A. Invasive otitis externa due to Aspergillus species: case report and review. Clin. Infect. Dis., 19, 866, 1994.
Tiwari, S., Singh, S. M., and Jain, S. Chronic bilateral suppurative otitis media caused by Aspergillus terreus. Mycoses, 38, 297, 1995.
Grigg, A. Prophylaxis and treatment of patients with aspergillosis: an overview, including the Royal Melbourne Hospital experience. J. Antimicrob. Chemother., 49 (Suppl. A), 75–80, 2002.
Harnacher, J., Spiliopoulos, A., Kurt, A. M., and Nicod, L. P. Pre-emptive therapy with azoles in lung transplant patients. Geneva Lung Transplantation Group. Eur. Respir. J., 13, 180–186, 1999.
MacMillan, M. L., Goodman, J. L., DeFor, T. E., and Weisdorf, D. J. Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance. Am. J. Med., 112, 369–379, 2002.
Kibbler, C. C. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients. Mycoses, 42 (Suppl. 2), 121–124, 1999.
Monforte, V., Roman, A., Gavalda, J., et al. Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors. J. Heart Lung Transplant., 20, 1274–1281, 2001.
Mele, L., Pagano, L., Equitani, F., and Leone, G. Case report. Secondary prophylaxis with liposomal amphotericin B after invasive aspergillosis following treatment for haematological malignancy. Mycoses, 44, 201–203, 2001.
Singhal, S., Ellis, R. W., Jones, S. G., et al. Targeted prophylaxis with amphotericin B lipid complex in liver transplantation. Liver Transplant., 6, 588–595, 2000.
Marr, K. A. Antifungal prophylaxis in hematopoietic stem cell transplant recipients. Oncology (Huntingt.), 15 (11 Suppl. 9), 1519, 2001.
Afeltra, J., Meis, J. F., Mouton, J. W., and Verweij, P. E. Prevention of invasive aspergillosis in AIDS by sulfamethoxazole. AIDS, 15, 1067–1068, 2001.
Naidu, J. and Singh, S. M. Aspergillus chevaliers (Mangin) Thom and Church: a new opportunistic pathogen of human cutaneous aspergillosis. Mycoses, 37, 271, 1994.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Georgiev, V.S. (2003). Aspergillus spp.. In: Opportunistic Infections. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-296-8_30
Download citation
DOI: https://doi.org/10.1007/978-1-59259-296-8_30
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-303-9
Online ISBN: 978-1-59259-296-8
eBook Packages: Springer Book Archive